Tate & Lyle’s SODA-LO™ Salt Microspheres "Most Innovative Health Ingredient of the Year" at NuW Excellence Awards 2012

| Filed in:

14 November, 2012 – Tate & Lyle’s ground-breaking, new salt-reduction ingredient, SODA-LO™ Salt Microspheres, was recognized as the "Heart Health and Circulatory Innovation of the Year" and as the overall "Most Innovative Health Ingredient of the Year" from the NuW Excellence Awards, which recognize individuals and business for their exemplary work and contribution to the industry.

"We are proud that a jury of experts recognized both the relevance of SODA-LOSalt Microspheres in today’s public health environment and the potential extraordinary value that it delivers to food manufacturers," said Andy Hoffman, Director of Health and Wellness Innovation, Tate & Lyle.

SODA-LO™ Salt Microspheres is a salt reduction ingredient that tastes, labels and functions like salt because it is salt. SODA-LO™ Salt Microspheres reduces salt levels by 25 to 50 percent in various applications including baked goods and salty snacks. SODA-LO™ Salt Microspheres has been created using a patent-pending technology that turns standard salt crystals into free-flowing crystalline microspheres. These smaller, lower-density crystals efficiently deliver salty taste by maximizing surface area relative to volume.

"The development of SODA-LO Salt Microspheres is a true case study in innovation helping to overcome a challenge – in this case reducing salt while maintaining taste – and we couldn’t be happier with the results and the commendation from NuW Excellence Awards," said Hoffman.

The winners of the categories were announced at the Messe Frankfurt where the Health Ingredients Europe is taking place until the 15th November 2012. Close to 40 entries were received into the awards with submissions coming from mainland Europe, Taiwan, China and the United States. The NuW Excellence Awards jury panel consisted of 9 leaders in the finished foods, beverages and ingredients industry.

About SODA-LO™ Salt Microspheres: A salt reduction ingredient, SODA-LO™ Salt Microspheres tastes, labels and functions like salt because it is salt. Tate & Lyle licensed SODA-LO® from Eminate Ltd, a wholly owned subsidiary of The University of Nottingham, UK, to commercialize it globally. Under the license agreement, Tate & Lyle assumes responsibility for commercialising the SODA-LO® salt reduction technology on a global basis including manufacturing, product development, sales and marketing. About Health Ingredients Europe & NuW Health ingredients Europe is part of the world-leading Food Ingredients, Natural Ingredients and Health Ingredients series of ingredients trade shows. These highly professional trade shows have been held successfully since 1986. Health ingredients Europe was launched in 2000 with Hi Europe (NuW) 2012 being the 7th edition of this show. Health Ingredients Europe will be joining NuW Nutrition + Wellness Solutions in 2012, creating a new exhibition that provides a complete 360-degree perspective of the entire nutrition and wellness industry. For more information, visit http://www.nuwsolutions.com About UBM plc UBM plc is a leading global company. We inform markets and bring the world's buyers and sellers together at events, online, in print and provide them with the information they need to do business successfully. We focus on serving professional commercial communities, from doctors to game developers, from journalists to jewellery traders, and from farmers to pharmacists around the world. Our 6,600 staff in more than 31 countries are organised into specialist teams that serve these communities, helping them to do business effectively and efficiently.

About Tate & Lyle: 
Tate & Lyle is a global provider of solutions and ingredients for food, beverage and industrial markets.

Tate & Lyle operates through two global divisions, Food & Beverage Solutions and Primary Products, supported by the Innovation and Commercial Development and Global Operations teams. Food & Beverage Solutions is focused on growth by building leading positions globally in the categories of beverages, dairy, and soups, sauces and dressings. Primary Products is focused on delivering steady earnings and generating cash.

Food & Beverage Solutions consists of: Texturants, including speciality starches; Sweeteners, including low- and no-calorie sweeteners; and a Health and Wellness portfolio comprising mainly speciality fibres; and Stabilisers and Functional Systems, which are bespoke ingredient blends that ensure foods retain their structure.

Primary Products consists of high-volume sweeteners, industrial starches and fermentation products (primarily acidulants).  It also sells co-products from the corn milling process as animal nutrition.

Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. In the year to 31 March 2020, Tate & Lyle sales totalled £2.9 billion. For more information, please visit http://www.tateandlyle.com or follow Tate & Lyle on Twitter or Linkedin.